Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21131 / DOSAGE - SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| LINEZOLID(UNII: ISQ9I6J12J) (LINEZOLID - UNII:ISQ9I6J12J) | LINEZOLID | 600mg in 300 |
Inactive Ingredients
| Ingredient Name | Hospira, Inc. | Teva Parenteral Medicines, Inc. | Fresenius Kabi Norge As | Mylan Institutional LLC |
|---|---|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||
| DEXTROSE MONOHYDRATE(LX22YL083G) | ||||
| DEXTROSE, UNSPECIFIED FORM(IY9XDZ35W2) | ||||
| HYDROCHLORIC ACID(QTT17582CB) | ||||
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||
| SODIUM HYDROXIDE(55X04QC32I) | ||||
| TRISODIUM CITRATE DIHYDRATE(B22547B95K) | ||||
| WATER(059QF0KO0R) |
